about
Gut microbiota-host interactions and juvenile idiopathic arthritisAnti-type II collagen antibodies, anti-CCP, IgA RF and IgM RF are associated with joint damage, assessed eight years after onset of juvenile idiopathic arthritis (JIA).Temporomandibular condylar alterations in juvenile idiopathic arthritis most common in longitudinally severe disease despite medical treatmentChanges in fecal microbiota and metabolomics in a child with juvenile idiopathic arthritis (JIA) responding to two treatment periods with exclusive enteral nutrition (EEN).Anti-inflammatory effect of exclusive enteral nutrition in patients with juvenile idiopathic arthritis.Psoriasis and associated variables in classification and outcome of juvenile idiopathic arthritis - an eight-year follow-up studyHigh-sensitive CRP as a predictive marker of long-term outcome in juvenile idiopathic arthritis.Incidence and predictors of Uveitis in juvenile idiopathic arthritis in a Nordic long-term cohort study.Ankle arthritis predicts polyarticular disease course and unfavourable outcome in children with juvenile idiopathic arthritis.Temporomandibular signs, symptoms, joint alterations and disease activity in juvenile idiopathic arthritis - an observational study.Anti-inflammatory effect by exclusive enteral nutrition (EEN) in a patient with juvenile idiopathic arthritis (JIA): brief report.Children with juvenile idiopathic arthritis frequently experience interruptions to their medical therapy.Non-HLA gene polymorphisms in juvenile idiopathic arthritis: associations with disease outcome.The Swedish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).Predicting unfavorable long-term outcome in juvenile idiopathic arthritis: results from the Nordic cohort study.HLA-B27 predicts a more chronic disease course in an 8-year followup cohort of patients with juvenile idiopathic arthritisSimultaneous detection of IgA and IgG antibodies against tissue transglutaminase: The preferred pre-biopsy test in childhood celiac diseaseCondylar alterations and facial growth in children with juvenile idiopathic arthritisComplement lectin pathway protein levels reflect disease activity in juvenile idiopathic arthritis: a longitudinal study of the Nordic JIA cohortLongterm Outcomes of Temporomandibular Joints in Juvenile Idiopathic Arthritis: 17 Years of Followup of a Nordic Juvenile Idiopathic Arthritis CohortEarly Self-Reported Pain in Juvenile Idiopathic Arthritis as Related to Long-Term Outcomes: Results From the Nordic Juvenile Idiopathic Arthritis Cohort StudyLong-Term Outcomes in Juvenile Idiopathic Arthritis: Eighteen Years of Follow-Up in the Population-Based Nordic Juvenile Idiopathic Arthritis CohortValidation of prediction models of severe disease course and non-achievement of remission in juvenile idiopathic arthritis: part 1-results of the Canadian model in the Nordic cohortEvaluation of screening for coeliac disease in children with juvenile idiopathic arthritisParticipation in school and physical education in juvenile idiopathic arthritis in a Nordic long-term cohort study
P50
Q26741980-4F37E88A-E259-49A1-9A1E-E1F7D950BC3CQ33770863-48407E63-869C-44FD-A58D-DA926FCE178EQ34227357-136050A6-B13B-4E76-94C6-31AFD38BCCA1Q35972166-4CD8B7D7-FF17-4B8C-BAE9-E505E8B94B59Q36068915-6102F8C6-F44C-4FC1-BE3B-E792591681E3Q37658174-502B4245-4EC1-4581-86DE-42756AB56A74Q38913955-A2CDD77A-6D6C-49AD-8925-68B295920B49Q40078094-5F2C7792-975A-4D8A-9F9C-678BBF4B52E8Q40693972-0722E4FB-F024-43D5-9211-B4B1D593A41CQ42839459-AD1640AF-7756-4BAA-8424-8B7F85A6D0CAQ46822043-000E33BB-0D34-4605-986E-5BE64500A3D4Q48544610-A68C41FB-728B-468C-B50F-641142845BB3Q51158792-2EA033B3-0864-4962-A43B-C1BB99D251CFQ52594855-300D52B9-8A8E-41A0-87F3-3A8610318B05Q55023560-16A9876C-0F52-46EB-816D-8F78A4B26D5AQ86520162-0A5185CD-68BC-4F38-9CF5-3202DF06BFF9Q87388204-9BA777B1-804D-4A81-A34F-FD497E66A7E4Q89799716-5B093325-4151-46F0-932C-8690994E3B7AQ89998078-1F1C366C-8908-40CC-B565-9CBD6D042673Q90114808-C01DF136-499A-44A3-8B97-D9E2D963F358Q90585226-AF4841CF-AB32-4C61-BCD6-6028893DF2B6Q91570607-25E1EC0C-FFF8-405E-AA88-94893E7C5CB8Q91729610-CA0E106E-996C-4BFD-89E6-8AF1EA17DB4FQ91846998-D8A06A45-3CF7-4562-8DCB-25AC67B549ABQ91895302-F93D4755-AEA1-4E53-B159-CA016AB51D5A
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Lillemor Berntson
@en
Lillemor Berntson
@nl
type
label
Lillemor Berntson
@en
Lillemor Berntson
@nl
prefLabel
Lillemor Berntson
@en
Lillemor Berntson
@nl
P108
P31
P496
0000-0003-3962-0453